Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
374.2 USD -1.16% Intraday chart for Intuitive Surgical, Inc. -3.68% +10.91%
Sales 2024 * 8B Sales 2025 * 9.25B Capitalization 133B
Net income 2024 * 1.83B Net income 2025 * 2.18B EV / Sales 2024 * 15.8 x
Net cash position 2024 * 5.78B Net cash position 2025 * 8.16B EV / Sales 2025 * 13.5 x
P/E ratio 2024 *
73.7 x
P/E ratio 2025 *
61.5 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Intuitive Surgical, Inc.

1 day-1.16%
1 week-4.61%
Current month-6.24%
1 month-4.70%
3 months+0.60%
6 months+35.81%
Current year+10.91%
More quotes
1 week
371.14
Extreme 371.14
392.29
1 month
371.14
Extreme 371.14
403.76
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
38.50
Extreme 38.4956
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 69 18-07-30
Director/Board Member 66 07-10-18
More insiders
Date Price Change Volume
24-04-17 374.2 -1.16% 1,625,516
24-04-16 378.6 +0.32% 1,602,985
24-04-15 377.4 -1.93% 1,650,717
24-04-12 384.8 -1.90% 1,476,001
24-04-11 392.3 +0.98% 1,186,680

Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
378.6 USD
Average target price
416.5 USD
Spread / Average Target
+10.02%
Consensus